Autoimmune Encephalitis Misdiagnosis in Adults
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Importance: Autoimmune encephalitis misdiagnosis can lead to harm. Objective: To determine the diseases misdiagnosed as autoimmune encephalitis and potential reasons for misdiagnosis. Design, Setting, and Participants: This retrospective multicenter study took place from January 1, 2014, to December 31, 2020, at autoimmune encephalitis subspecialty outpatient clinics including Mayo Clinic (n = 44), University of Oxford (n = 18), University of Texas Southwestern (n = 18), University of California, San Francisco (n = 17), Washington University in St Louis (n = 6), and University of Utah (n = 4). Inclusion criteria were adults (age ≥18 years) with a prior autoimmune encephalitis diagnosis at a participating center or other medical facility and a subsequent alternative diagnosis at a participating center. A total of 393 patients were referred with an autoimmune encephalitis diagnosis, and of those, 286 patients with true autoimmune encephalitis were excluded. Main Outcomes and Measures: Data were collected on clinical features, investigations, fulfillment of autoimmune encephalitis criteria, alternative diagnoses, potential contributors to misdiagnosis, and immunotherapy adverse reactions. Results: A total of 107 patients were misdiagnosed with autoimmune encephalitis, and 77 (72%) did not fulfill diagnostic criteria for autoimmune encephalitis. The median (IQR) age was 48 (35.5-60.5) years and 65 (61%) were female. Correct diagnoses included functional neurologic disorder (27 [25%]), neurodegenerative disease (22 [20.5%]), primary psychiatric disease (19 [18%]), cognitive deficits from comorbidities (11 [10%]), cerebral neoplasm (10 [9.5%]), and other (18 [17%]). Onset was acute/subacute in 56 (52%) or insidious (>3 months) in 51 (48%). Magnetic resonance imaging of the brain was suggestive of encephalitis in 19 of 104 patients (18%) and cerebrospinal fluid (CSF) pleocytosis occurred in 16 of 84 patients (19%). Thyroid peroxidase antibodies were elevated in 24 of 62 patients (39%). Positive neural autoantibodies were more frequent in serum than CSF (48 of 105 [46%] vs 7 of 91 [8%]) and included 1 or more of GAD65 (n = 14), voltage-gated potassium channel complex (LGI1 and CASPR2 negative) (n = 10), N-methyl-d-aspartate receptor by cell-based assay only (n = 10; 6 negative in CSF), and other (n = 18). Adverse reactions from immunotherapies occurred in 17 of 84 patients (20%). Potential contributors to misdiagnosis included overinterpretation of positive serum antibodies (53 [50%]), misinterpretation of functional/psychiatric, or nonspecific cognitive dysfunction as encephalopathy (41 [38%]). Conclusions and Relevance: When evaluating for autoimmune encephalitis, a broad differential diagnosis should be considered and misdiagnosis occurs in many settings including at specialized centers. In this study, red flags suggesting alternative diagnoses included an insidious onset, positive nonspecific serum antibody, and failure to fulfill autoimmune encephalitis diagnostic criteria. Autoimmune encephalitis misdiagnosis leads to morbidity from unnecessary immunotherapies and delayed treatment of the correct diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
Self-citationHollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279 · cited 1×
“The median (IQR) time from onset to the correct diagnosis was 16 (7-40) months.”
BackgroundIrani, S. R., Alexander, S., Waters, P., Kleopa, K. A., Pettingill, P., Zuliani, L., Peles, E., Buckley, C., Lang, B., & Vincent, A. (2010) · Brain · doi:10.1093/brain/awq213 · Cited by 1,359
Self-citationBijl, R. V., Ravelli, A., & van Zessen, G. (1998) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050098 · Cited by 1,216 · cited 1×
“The median (IQR) time from onset to the correct diagnosis was 16 (7-40) months.”
BackgroundClinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis
Wilson, M. R., Sample, H. A., Zorn, K. C., Arevalo, S., Yu, G., Neuhaus, J., Federman, S., Stryke, D., Briggs, B., Langelier, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1803396 · Cited by 1,067
Self-citationGilhus, N. E. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1602678 · Cited by 1,048
Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis
Dubey, D., Pittock, S. J., Kelly, C. R., McKeon, A., Lopez‐Chiriboga, A. S., Lennon, V. A., Gadoth, A., Smith, C. Y., Bryant, S. C., Klein, C. J., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25131 · Cited by 777
Self-citationCalcium-Channel Antibodies in the Lambert–Eaton Syndrome and Other Paraneoplastic Syndromes
Lennon, V. A., Kryzer, T. J., Griesmann, G. E., O'Suilleabhain, P. E., Windebank, A. J., Woppmann, A., Miljanich, G. P., & Lambert, E. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322203 · Cited by 603
Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management
Abboud, H., Probasco, J. C., Irani, S., Ances, B., Benavides, D. R., Bradshaw, M., Christo, P. P., Dale, R. C., Fernandez-Fournier, M., Flanagan, E. P., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325300 · Cited by 554
Self-citationWho is referred to neurology clinics?—The diagnoses made in 3781 new patients
Stone, J., Carson, A., Duncan, R., Roberts, R., Warlow, C., Hibberd, C., Coleman, R., Cull, R., Murray, G., Pelosi, A., et al. (2010) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2010.05.011 · Cited by 536
Clinical manifestations of the anti-IgLON5 disease
Gaig, C., Graus, F., Compta, Y., Högl, B., Bataller, L., Brüggemann, N., Giordana, C., Heidbreder, A., Kotschet, K., Lewerenz, J., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003887 · Cited by 421
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease
Hermann, P., Appleby, B., Brandel, J.-P., Caughey, B., Collins, S., Geschwind, M. D., Green, A., Haïk, S., Kovacs, G. G., Ladogana, A., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30477-4 · Cited by 361
Self-citationThe contemporary spectrum of multiple sclerosis misdiagnosis
Solomon, A. J., Bourdette, D. N., Cross, A. H., Applebee, A., Skidd, P. M., Howard, D. B., Spain, R. I., Cameron, M. H., Kim, E., Mass, M. K., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003152 · Cited by 334
Self-citationGAD antibodies in neurological disorders — insights and challenges
Graus, F., Saiz, A., & Dalmau, J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0359-x · Cited by 249
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
Simpson-Yap, S., De Brouwer, E., Kalincik, T., Rijke, N., Hillert, J. A., Walton, C., Edan, G., Moreau, Y., Spelman, T., Geys, L., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012753 · Cited by 236
Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing
Sechi, E., Buciuc, M., Pittock, S. J., Chen, J. J., Fryer, J. P., Jenkins, S. M., Budhram, A., Weinshenker, B. G., Lopez-Chiriboga, A. S., Tillema, J.-M., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.0912 · Cited by 234
Self-citationSeizure-induced brain lesions: A wide spectrum of variably reversible MRI abnormalities
Cianfoni, A., Caulo, M., Cerase, A., Della Marca, G., Falcone, C., Di Lella, G. M., Gaudino, S., Edwards, J., & Colosimo, C. (2013) · European Journal of Radiology · doi:10.1016/j.ejrad.2013.05.020 · Cited by 205
Functional cognitive disorder: dementia’s blind spot
Ball, H. A., McWhirter, L., Ballard, C., Bhome, R., Blackburn, D. J., Edwards, M. J., Fleming, S. M., Fox, N. C., Howard, R., Huntley, J., et al. (2020) · Brain · doi:10.1093/brain/awaa224 · Cited by 203
Voltage-Gated Potassium Channel Autoimmunity Mimicking Creutzfeldt-Jakob Disease
Geschwind, M. D., Tan, K. M., Lennon, V. A., Barajas, R. F., Haman, A., Klein, C. J., Josephson, S. A., & Pittock, S. J. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1341 · Cited by 193
Self-citationGAD65 neurological autoimmunity
McKeon, A., & Tracy, J. A. (2017) · Muscle & Nerve · doi:10.1002/mus.25565 · Cited by 185
Self-citationClinical spectrum of high-titre GAD65 antibodies
Budhram, A., Sechi, E., Flanagan, E. P., Dubey, D., Zekeridou, A., Shah, S. S., Gadoth, A., Naddaf, E., McKeon, A., Pittock, S. J., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325275 · Cited by 184
Self-citationWalikonis, J., & Lennon, V. A. (1998) · Mayo Clinic Proceedings · doi:10.4065/73.12.1161 · Cited by 164
COVID ‐19 Vaccine Response in People with Multiple Sclerosis
Tallantyre, E. C., Vickaryous, N., Anderson, V., Asardag, A. N., Baker, D., Bestwick, J., Bramhall, K., Chance, R., Evangelou, N., George, K., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26251 · Cited by 158
Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
Lang, B., Makuch, M., Moloney, T. C., Dettmann, I., Mindorf, S., Probst, C., Stoecker, W., Buckley, C. J., Newton, C. R. J. C., Leite, M. I., et al. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314758 · Cited by 146
Self-citationEpidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France
Hébert, J., Riche, B., Vogrig, A., Muñiz‐Castrillo, S., Joubert, B., Picard, G., Rogemond, V., Psimaras, D., Alentorn, A., Berzero, G., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000883 · Cited by 135
Antibody-associated CNS syndromes without signs of inflammation in the elderly
Escudero, D., Guasp, M., Ariño, H., Gaig, C., Martínez‐Hernández, E., Dalmau, J. O., & Graus, F. (2017) · Neurology · doi:10.1212/wnl.0000000000004541 · Cited by 119
Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis
Guasp, M., Giné-Servén, E., Maudes, E., Rosa-Justícia, M., Martínez‐Hernández, E., Boix-Quintana, E., Bioque, M., Casado, V., Módena-Ouarzi, Y., Guanyabens, N., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012191 · Cited by 115
Zalewski, N. L., Lennon, V. A., Lachance, D. H., Klein, C. J., Pittock, S. J., & McKeon, A. B. (2016) · Muscle & Nerve · doi:10.1002/mus.25027 · Cited by 108
Self-citationFrequencies of neuronal autoantibodies in healthy controls: Estimation of disease specificity
Lang, K., & Prüß, H. (2017) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000386 · Cited by 82
Neural Antibody Testing in Patients with Suspected Autoimmune Encephalitis
Budhram, A., Dubey, D., Sechi, E., Flanagan, E. P., Yang, L., Bhayana, V., McKeon, A. B., Pittock, S. J., & Mills, J. R. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa254 · Cited by 78
Self-citationBastiaansen, A. E. M., de Bruijn, M. A. A. M., Schuller, S. L., Martínez‐Hernández, E., Brenner, J., Paunovic, M., Crijnen, Y. S., Mulder, M. J. H. L., Schreurs, M. W. J., de Graaff, E., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001127 · Cited by 78
Searching for autoimmune encephalitis: Beware of normal CSF
Hébert, J., Gros, P., Lapointe, S., Amtashar, F. S., Steriade, C., Maurice, C., Wennberg, R. A., Day, G. S., & Tang‐Wai, D. F. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577285 · Cited by 63
Self-citationWalzl, D., Solomon, A. J., & Stone, J. (2022) · Journal of Neurology · doi:10.1007/s00415-021-10436-6 · Cited by 62 · cited 1×
“The median (IQR) time from onset to the correct diagnosis was 16 (7-40) months.”
BackgroundSelf-citationBrain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis
Valencia-Sánchez, C., Pittock, S. J., Mead‐Harvey, C., Dubey, D., Flanagan, E. P., Lopez-Chiriboga, A. S., Trenerry, M. R., Zalewski, N. L., Ζεκερίδου, Α., & McKeon, A. B. (2021) · Brain Communications · doi:10.1093/braincomms/fcaa233 · Cited by 62
Self-citationLi, Y., Jammoul, A., Mente, K., Li, J., Shields, R. W., Vernino, S. A., & Rae-Grant, A. D. (2014) · Muscle & Nerve · doi:10.1002/mus.24559 · Cited by 56
Self-citationTheorell, J., Ramberger, M., Harrison, R., Mgbachi, V. C., Jacobson, L. W., Waters, P. J., Erhardt, S., Sellgren, C. M., Červenka, S., Piehl, F., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01701-3 · Cited by 38
Self-citationParaneoplastic disorders of the nervous system
Flanagan, E. P. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10570-1 · Cited by 22
Self-citationNeuroimmunogastroenterology: At the Interface of Neuroimmunology and Gastroenterology
Sanchez, J. M. S., McNally, J. S., Cortez, M. M., Hemp, J., Pace, L., & Clardy, S. L. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00787 · Cited by 15
Self-citationParaneoplastic Disorders of the Nervous System
Flanagan, E. P. (2020) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000941 · Cited by 15
Self-citationPrimary HIV infection presenting as limbic encephalitis and rhabdomyolysis
Ferrada, M. A., Xie, Y. L., & Nuermberger, E. L. (2014) · International Journal of STD & AIDS · doi:10.1177/0956462414560777 · Cited by 13
Poon, J. T., Salzman, K. L., Clardy, S. L., & Soldán, M. M. P. (2021) · The Neurologist · doi:10.1097/nrl.0000000000000374 · Cited by 3
Self-citation
Cited by
Clinical Utility of CSF Correction Factors for Traumatic Lumbar Puncture in Adults
Zhou, R. W., Sangam, K., & Budhram, A. (2024) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200350 · Cited by 3
Metadata
- Authors
- Flanagan, E. P., Geschwind, M. D., Lopez-Chiriboga, A. S., Blackburn, K. M., Turaga, S., Binks, S., Zitser, J., Gelfand, J. M., Day, G. S., Dunham, S. R., Rodenbeck, S. J., Clardy, S. L., Solomon, A. J., Pittock, S. J., McKeon, A., Dubey, D., Zekeridou, A., Toledano, M., Turner, L. E., Vernino, S., & Irani, S. R.
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2023-01-01
- Volume
- 80
- Issue
- 1
- Pages
- 30
- ISSN
- 2168-6149 (ISSN-L)
- OpenAlex
- W4310130646
- Cited by
- 303
- References
- 42
- FWCI
- 26.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.